Literature DB >> 9805364

Chemical structure of antithrombin-active Rhamnan sulfate from Monostrom nitidum.

N Harada1, M Maeda.   

Abstract

Rhamnan sulfate was extracted with boiling water from the cell wall of Monostroma nitridum, and the resulting extract was purified by ion-exchange and size-exclusion chromatography. The polysaccharide, which is regarded as a homopolysaccharide, was 6-fold more antithrombin-active than the heparin standard. The antithrombin activity was decreased, by desulfation, although the non-active product still retained 8% of the sulfate ester. A comparative structural study of the intact rhamnan sulfate and rhamnan, its desulfated product, by periodate oxidation, Smith degradation and methylation analysis revealed the rhamnan sulfate to consist of alpha-1,3-linked L-rhamnose residues, some of which were substituted with sulfate groups mainly at position O-2. Minor amounts of internal 1,2-linked rhamnose and branched rhamnose linkages were also detected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805364     DOI: 10.1271/bbb.62.1647

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  17 in total

1.  Endothelial Glycocalyx-Mediated Nitric Oxide Production in Response to Selective AFM Pulling.

Authors:  Anne Marie W Bartosch; Rick Mathews; John M Tarbell
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

2.  Rhamnan sulfate extracted from Monostroma nitidum attenuates blood coagulation and inflammation of vascular endothelial cells.

Authors:  Takayuki Okamoto; Nobuyuki Akita; Masahiro Terasawa; Tatsuya Hayashi; Koji Suzuki
Journal:  J Nat Med       Date:  2019-02-22       Impact factor: 2.343

3.  Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial.

Authors:  Yasuhito Shimada; Masahiro Terasawa; Fumiyoshi Okazaki; Hiroko Nakayama; Liqing Zang; Kaoru Nishiura; Koichi Matsuda; Norihiro Nishimura
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

Review 4.  Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches.

Authors:  Tiago H Silva; Anabela Alves; Elena G Popa; Lara L Reys; Manuela E Gomes; Rui A Sousa; Simone S Silva; João F Mano; Rui L Reis
Journal:  Biomatter       Date:  2012 Oct-Dec

Review 5.  Chemical structures and bioactivities of sulfated polysaccharides from marine algae.

Authors:  Guangling Jiao; Guangli Yu; Junzeng Zhang; H Stephen Ewart
Journal:  Mar Drugs       Date:  2011-02-08       Impact factor: 6.085

Review 6.  Overview on biological activities and molecular characteristics of sulfated polysaccharides from marine green algae in recent years.

Authors:  Lingchong Wang; Xiangyu Wang; Hao Wu; Rui Liu
Journal:  Mar Drugs       Date:  2014-09-25       Impact factor: 5.118

Review 7.  Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.

Authors:  Ronodeep Mitra; Gerard Leland O'Neil; Ian Chandler Harding; Ming Jie Cheng; Solomon Arko Mensah; Eno Essien Ebong
Journal:  Curr Atheroscler Rep       Date:  2017-11-10       Impact factor: 5.113

8.  Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication.

Authors:  Solomon A Mensah; Ming J Cheng; Homa Homayoni; Brian D Plouffe; Arthur J Coury; Eno E Ebong
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

9.  Structural Characteristics and Anticoagulant Property In Vitro and In Vivo of a Seaweed Sulfated Rhamnan.

Authors:  Xue Liu; Shuyao Wang; Sujian Cao; Xiaoxi He; Ling Qin; Meijia He; Yajing Yang; Jiejie Hao; Wenjun Mao
Journal:  Mar Drugs       Date:  2018-07-20       Impact factor: 5.118

10.  Anti-Influenza A Virus Activity of Rhamnan Sulfate from Green Algae Monostroma nitidum in Mice with Normal and Compromised Immunity.

Authors:  Masahiro Terasawa; Kyoko Hayashi; Jung-Bum Lee; Kaoru Nishiura; Koichi Matsuda; Toshimitsu Hayashi; Toshio Kawahara
Journal:  Mar Drugs       Date:  2020-05-13       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.